Optum Health Aims to Revive UnitedHealth Group's Flagging Stock
UnitedHealth Group (NYSE:UNH) has faced challenges in recent times, but its subsidiary Optum Health is seen as a potential catalyst for growth. The health insurance giant's stock price has struggled to regain momentum, dropping from $410 to around $340 over the past year.
Optum Health is a key driver of UnitedHealth Group's non-insurance business, accounting for nearly 40% of the company's total revenue. Its services include pharmacy benefits management, care delivery, and data-driven insights that help improve patient outcomes.
The subsidiary has been expanding its reach through acquisitions, including the purchase of Change Healthcare in a deal worth over $8 billion. This move is expected to enhance Optum Health's capabilities in population health management and digital transformation.